The Science Behind Brauer's Probiotic Strains

Studies for Bifidobacterium animalis subsp. lactis BB-12 

• Chen, K., Zhang, G., Xie, H., You, L., Li, H., Zhang, Y., Du, C., Xu, S., Melsaether, C. and Yuan, S., 2021. Efficacy of Bifidobacterium animalis subsp. lactis, BB-12® on infant colic – a randomised, double-blinded, placebo-controlled study. Beneficial Microbes, 12(6), pp.531-540.
• Nocerino, R., De Filippis, F., Cecere, G., Marino, A., Micillo, M., Di Scala, C., de Caro, C., Calignano, A., Bruno, C., Paparo, L., Iannicelli, A., Cosenza, L., Maddalena, Y., della Gatta, G., Coppola, S., Carucci, L., Ercolini, D. and Berni Canani, R., 2019. The therapeutic efficacy of Bifidobacterium animalis subsp. lactis BB-12® in infant colic: A randomised, double blind, placebo-controlled trial. Alimentary Pharmacology & Therapeutics, 51(1), pp.110-120. Funded by Sofar S.p.A.

Studies for M-16

• Bennet, R., Nord, C. and Zetterström, R., 1992. Transient colonization of the gut of newborn infants by orally administered bifidobacteria and lactobacilli. Acta Paediatrica, 81(10), pp.784-787.
• Russo, M., Giugliano, F., Quitadamo, P., Mancusi, V., Miele, E. and Staiano, A., 2017. Efficacy of a mixture of probiotic agents as complementary therapy for chronic functional constipation in childhood. Italian Journal of Pediatrics, 43(1).
• Abrahamse-Berkeveld, M., Alles, M., Franke-Beckmann, E., Helm, K., Knecht, R., Köllges, R., Sandner, B., Knol, J., Ben Amor, K. and Bufe, A., 2016. Infant formula containing galacto-and fructo-oligosaccharides and Bifidobacterium breve M-16V supports adequate growth and tolerance in healthy infants in a randomised, controlled, double-blind, prospective, multicentre study. Journal of Nutritional Science, 5.

Studies for Bifidobacterium lactis HN019

• Sanders, M. E., 2006. Summary of Probiotc Activites of Bifidobacterium lactis HN019. Journal of Clinical Gastroenterology. Vol 40, Num 9, Oct 2006.pp. 776 – 783
• Sazawal, S., Dhingra, U., Hiremath, G., Sarkar, A., Dhingra, P., Dutta, A., Menon, V. and Black, R., 2010. Effects of Bifidobacterium lactis HN019 and Prebiotic Oligosaccharide Added to Milk on Iron Status, Anemia, and Growth Among Children 1 to 4 Years Old. Journal of Pediatric Gastroenterology & Nutrition, 51(3), pp.341-346.
• Sazawal, S., Dhingra, U., Hiremath, G., Sarkar, A., Dhingra, P., Dutta, A., Verma, P., Menon, V. and Black, R., 2010. Prebiotic and Probiotic Fortified Milk in Prevention of Morbidities among Children: Community-Based, Randomized, Double-Blind, Controlled Trial. PLoS ONE, 5(8), p.e12164.
• Dekker, J., Xu, L., Hong, Q. and Xioayang, S., Bifidobacterium animalis subsp.lactis HN019 protects against respiratory tract infections in Chinese infants. NUTRITION: Nutrition and health outcomes.

Studies for Lactobacillus rhamnosus GG (L-GG)

• Hatakka, k., Savilahti, E., Pönkä, A.,  Meurman J. H., Poussa, T., Näse, L., Saxelin, M. and Korpela, R., 2001. Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. BMJ VOLUME 322 2 JUNE 2001. bmj.com
• Liu, S., Hu, P., Du, X., Zhou, T., and Pei, X., 2013.  Lactobacillus rhamnosus GG Supplementation for Preventing Respiratory Infections in Children: A Meta-analysis of Randomized, Placebo-controlled Trials. INDIAN PEDIATRICS VOLUME 50 – APRIL 16, 2013 pp. 337 – 381.